Journey Medical CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Vanguard Capital Management has disclosed a beneficial ownership of 774,556 shares, representing 3.59% of the outstanding common stock of Journey Medical Corp.
NASDAQ
Wasatch Advisors LP has reported beneficial ownership of 2,858,930 shares, representing 13.3% of the class, in Journey Medical Corp as of June 30, 2026.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.65% of Journey Medical Corp's common stock as of March 31, 2026.
NASDAQ
Wasatch Advisors LP has reported beneficial ownership of 2,133,370 shares, representing 10.0% of the outstanding common stock of Journey Medical Corp.
NASDAQ
Wasatch Advisors LP has increased its beneficial ownership in Journey Medical Corp to 6.7% of common stock, holding over 1.15 million shares.
NASDAQ
Tang Capital Management, LLC and affiliated entities, including Kevin Tang, have disclosed a passive beneficial ownership of 8.0% in Journey Medical Corporation's common stock.
NASDAQ
Wasatch Advisors LP has filed a Schedule 13G, reporting a passive beneficial ownership of 5.4% of Journey Medical Corp's common stock as of March 31, 2025.